Ultrasound of peripheral nerves in acromegaly: Changes at 1-year follow-up

Eugenia Resmini, Alberto Tagliafico, Raffaella Nizzo, Federico Bianchi, Francesco Minuto, Lorenzo Derchi, Carlo Martinoli, Diego Ferone

Research output: Contribution to journalArticle

Abstract

Context We have previously demonstrated peripheral nerve enlargement in acromegaly. Objective The aim of this study was to use ultrasound (US) to assess any changes in the peripheral nerves of patients with acromegaly 1 year after the first evaluation. Patients We prospectively examined the median and ulnar nerve cross-sectional area (CSA) in 34 non-diabetic, patients with acromegaly (18 females and 16 males; 18-79 years) and 34 age-, sex-, BMI-matched controls, using a 17-5 MHz US probe. Intervention The median nerve was examined at the mid-forearm (MN-f) and at the carpal tunnel (MN-Ct) levels; the ulnar nerve at mid-forearm (UN-f) and at distal arm (UN-a). Patients were grouped according to the clinical control of the disease: 'improved'; 'always controlled'; 'always uncontrolled'; and 'worsened'. Results The median nerve at mid-forearm (MN-f), the ulnar nerve at mid-forearm (UN-f) and at distal arm (UN-a) were significantly reduced after 1-year follow-up in all patients (P <0·001, P <0·008, P <0·012, respectively). In the 'improved' group, there was a significant reduction of median nerve CSA examined at mid-forearm (MN-f) (P = 0·02), and distal arm ulnar nerve CSA (UN-a) (P = 0·002). In the other groups no statistically significant differences in ultrasound parameters were recorded. However, UN-a, UN-f, MN-f, MN-ct were still significantly higher in all groups compared with controls (P <0·001). Conclusion These data demonstrate that median and ulnar nerves CSA are reduced after 1 year follow-up, in line with the reduction of GH/IGF-I levels. However, as the control of the disease incompletely reverts nerve enlargement, this phenomenon could be only partially reversible.

Original languageEnglish
Pages (from-to)220-225
Number of pages6
JournalClinical Endocrinology
Volume71
Issue number2
DOIs
Publication statusPublished - Aug 2009

Fingerprint

Ulnar Nerve
Acromegaly
Median Nerve
Peripheral Nerves
Forearm
Arm
Wrist
Insulin-Like Growth Factor I

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Ultrasound of peripheral nerves in acromegaly : Changes at 1-year follow-up. / Resmini, Eugenia; Tagliafico, Alberto; Nizzo, Raffaella; Bianchi, Federico; Minuto, Francesco; Derchi, Lorenzo; Martinoli, Carlo; Ferone, Diego.

In: Clinical Endocrinology, Vol. 71, No. 2, 08.2009, p. 220-225.

Research output: Contribution to journalArticle

Resmini, E, Tagliafico, A, Nizzo, R, Bianchi, F, Minuto, F, Derchi, L, Martinoli, C & Ferone, D 2009, 'Ultrasound of peripheral nerves in acromegaly: Changes at 1-year follow-up', Clinical Endocrinology, vol. 71, no. 2, pp. 220-225. https://doi.org/10.1111/j.1365-2265.2008.03468.x
Resmini, Eugenia ; Tagliafico, Alberto ; Nizzo, Raffaella ; Bianchi, Federico ; Minuto, Francesco ; Derchi, Lorenzo ; Martinoli, Carlo ; Ferone, Diego. / Ultrasound of peripheral nerves in acromegaly : Changes at 1-year follow-up. In: Clinical Endocrinology. 2009 ; Vol. 71, No. 2. pp. 220-225.
@article{f024ba1483db43e9b4398181d19a27c8,
title = "Ultrasound of peripheral nerves in acromegaly: Changes at 1-year follow-up",
abstract = "Context We have previously demonstrated peripheral nerve enlargement in acromegaly. Objective The aim of this study was to use ultrasound (US) to assess any changes in the peripheral nerves of patients with acromegaly 1 year after the first evaluation. Patients We prospectively examined the median and ulnar nerve cross-sectional area (CSA) in 34 non-diabetic, patients with acromegaly (18 females and 16 males; 18-79 years) and 34 age-, sex-, BMI-matched controls, using a 17-5 MHz US probe. Intervention The median nerve was examined at the mid-forearm (MN-f) and at the carpal tunnel (MN-Ct) levels; the ulnar nerve at mid-forearm (UN-f) and at distal arm (UN-a). Patients were grouped according to the clinical control of the disease: 'improved'; 'always controlled'; 'always uncontrolled'; and 'worsened'. Results The median nerve at mid-forearm (MN-f), the ulnar nerve at mid-forearm (UN-f) and at distal arm (UN-a) were significantly reduced after 1-year follow-up in all patients (P <0·001, P <0·008, P <0·012, respectively). In the 'improved' group, there was a significant reduction of median nerve CSA examined at mid-forearm (MN-f) (P = 0·02), and distal arm ulnar nerve CSA (UN-a) (P = 0·002). In the other groups no statistically significant differences in ultrasound parameters were recorded. However, UN-a, UN-f, MN-f, MN-ct were still significantly higher in all groups compared with controls (P <0·001). Conclusion These data demonstrate that median and ulnar nerves CSA are reduced after 1 year follow-up, in line with the reduction of GH/IGF-I levels. However, as the control of the disease incompletely reverts nerve enlargement, this phenomenon could be only partially reversible.",
author = "Eugenia Resmini and Alberto Tagliafico and Raffaella Nizzo and Federico Bianchi and Francesco Minuto and Lorenzo Derchi and Carlo Martinoli and Diego Ferone",
year = "2009",
month = "8",
doi = "10.1111/j.1365-2265.2008.03468.x",
language = "English",
volume = "71",
pages = "220--225",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Ultrasound of peripheral nerves in acromegaly

T2 - Changes at 1-year follow-up

AU - Resmini, Eugenia

AU - Tagliafico, Alberto

AU - Nizzo, Raffaella

AU - Bianchi, Federico

AU - Minuto, Francesco

AU - Derchi, Lorenzo

AU - Martinoli, Carlo

AU - Ferone, Diego

PY - 2009/8

Y1 - 2009/8

N2 - Context We have previously demonstrated peripheral nerve enlargement in acromegaly. Objective The aim of this study was to use ultrasound (US) to assess any changes in the peripheral nerves of patients with acromegaly 1 year after the first evaluation. Patients We prospectively examined the median and ulnar nerve cross-sectional area (CSA) in 34 non-diabetic, patients with acromegaly (18 females and 16 males; 18-79 years) and 34 age-, sex-, BMI-matched controls, using a 17-5 MHz US probe. Intervention The median nerve was examined at the mid-forearm (MN-f) and at the carpal tunnel (MN-Ct) levels; the ulnar nerve at mid-forearm (UN-f) and at distal arm (UN-a). Patients were grouped according to the clinical control of the disease: 'improved'; 'always controlled'; 'always uncontrolled'; and 'worsened'. Results The median nerve at mid-forearm (MN-f), the ulnar nerve at mid-forearm (UN-f) and at distal arm (UN-a) were significantly reduced after 1-year follow-up in all patients (P <0·001, P <0·008, P <0·012, respectively). In the 'improved' group, there was a significant reduction of median nerve CSA examined at mid-forearm (MN-f) (P = 0·02), and distal arm ulnar nerve CSA (UN-a) (P = 0·002). In the other groups no statistically significant differences in ultrasound parameters were recorded. However, UN-a, UN-f, MN-f, MN-ct were still significantly higher in all groups compared with controls (P <0·001). Conclusion These data demonstrate that median and ulnar nerves CSA are reduced after 1 year follow-up, in line with the reduction of GH/IGF-I levels. However, as the control of the disease incompletely reverts nerve enlargement, this phenomenon could be only partially reversible.

AB - Context We have previously demonstrated peripheral nerve enlargement in acromegaly. Objective The aim of this study was to use ultrasound (US) to assess any changes in the peripheral nerves of patients with acromegaly 1 year after the first evaluation. Patients We prospectively examined the median and ulnar nerve cross-sectional area (CSA) in 34 non-diabetic, patients with acromegaly (18 females and 16 males; 18-79 years) and 34 age-, sex-, BMI-matched controls, using a 17-5 MHz US probe. Intervention The median nerve was examined at the mid-forearm (MN-f) and at the carpal tunnel (MN-Ct) levels; the ulnar nerve at mid-forearm (UN-f) and at distal arm (UN-a). Patients were grouped according to the clinical control of the disease: 'improved'; 'always controlled'; 'always uncontrolled'; and 'worsened'. Results The median nerve at mid-forearm (MN-f), the ulnar nerve at mid-forearm (UN-f) and at distal arm (UN-a) were significantly reduced after 1-year follow-up in all patients (P <0·001, P <0·008, P <0·012, respectively). In the 'improved' group, there was a significant reduction of median nerve CSA examined at mid-forearm (MN-f) (P = 0·02), and distal arm ulnar nerve CSA (UN-a) (P = 0·002). In the other groups no statistically significant differences in ultrasound parameters were recorded. However, UN-a, UN-f, MN-f, MN-ct were still significantly higher in all groups compared with controls (P <0·001). Conclusion These data demonstrate that median and ulnar nerves CSA are reduced after 1 year follow-up, in line with the reduction of GH/IGF-I levels. However, as the control of the disease incompletely reverts nerve enlargement, this phenomenon could be only partially reversible.

UR - http://www.scopus.com/inward/record.url?scp=67650337264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650337264&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2265.2008.03468.x

DO - 10.1111/j.1365-2265.2008.03468.x

M3 - Article

C2 - 19178522

AN - SCOPUS:67650337264

VL - 71

SP - 220

EP - 225

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 2

ER -